Metsera, Inc. Responds to Pfizer Litigation and Announces Proposed Acquisition

Summary

On October 31, 2025, Metsera, Inc. issued a statement in response to litigation filed by Pfizer Inc. Metsera disagrees with Pfizer's allegations and plans to address them in court. Additionally, the company disclosed Pfizer's proposed acquisition, which involves several risks and uncertainties, including regulatory approvals and potential integration challenges.